Gestational diabetes mellitus: Antenatal variables as predictors of postpartum glucose intolerance

1995 ◽  
Vol 86 (1) ◽  
pp. 97-101 ◽  
Author(s):  
L GREENBERG ◽  
T MOORE ◽  
H MURPHY
PEDIATRICS ◽  
2008 ◽  
Vol 122 (6) ◽  
pp. 1229-1234 ◽  
Author(s):  
W. H. Tam ◽  
R. C. W. Ma ◽  
X. Yang ◽  
G. T. C. Ko ◽  
P. C. Y. Tong ◽  
...  

2020 ◽  
Author(s):  
Naohisa Masuko ◽  
Kenji Tanimura ◽  
Nobue Kojima ◽  
Hitomi Imafuku ◽  
Masashi Deguchi ◽  
...  

Abstract This prospective cohort study aimed to evaluate the risk factors for pregnancy complications and postpartum glucose intolerance (GI) in women with gestational diabetes mellitus (GDM). A total of 140 women with GDM were enrolled. Of these, 115 underwent a 75-g oral glucose tolerance test (OGTT) at 12 weeks after delivery. Clinical factors and parameters in the antepartum 75-g OGTT associated with pregnancy complications and postpartum GI were evaluated. Women with GDM experienced pregnancy complications, including hypertensive disorders of pregnancy (HDP, n=19), preterm delivery (PD, n=17), heavy-for-date (HFD, n=19), and light-for-date (LFD, n=12), and 22 of the 115 women with GDM developed postpartum GI. The univariate and multivariable logistic regression analyses revealed the following risk factors: histories of hypertension (odds ratio [OR], 23.8; 95% confidence interval [CI], 4.2–134.7; p<0.01) for HDP; histories of hypertension (OR, 9.8; 95% CI, 2.5–38.9; p<0.01) for PD; HbA1c levels (OR, 7.6; 95% CI, 1.5–37.9; p<0.05) for HFD; and oral deposition index (DI) (OR, 0.1; 95% CI, 0.02–0.7; p<0.01) for postpartum GI. Higher HbA1c levels and lower oral DI on the antepartum 75-g OGTT may be useful markers for identifying GDM women who are at high risk for HFD and postpartum GI, respectively.


2021 ◽  
Vol 1 (1) ◽  
pp. 57-59
Author(s):  
Sumi Singh

Gestational diabetes mellitus (GDM) can be defined as any degree of glucose intolerance with onset or first recognition during pregnancy. Screening for GDM is done usually at 24-28 weeks of gestation. In this case a 27-year-old primigravida who was diagnosed as GDM after a one step approach at 22 weeks of pregnancy. Institution of management early by the help of one step diagnosis was associated with successful outcome. The case highlights the importance of diagnosing GDM early especially in developing countries where resources are limited.


Author(s):  
OJS Admin

Gestational Diabetes Mellitus (GDM) is defined as glucose intolerance of varying degree with onset or first recognition during pregnancy. Prevalence of GDM is known to vary widely depending on the region of the country, dietary habits, and socio-economic status.


1997 ◽  
Vol 59 (3) ◽  
pp. 229-232 ◽  
Author(s):  
G Forsbach ◽  
C Cantú-Diaz ◽  
J Vázquez-Lara ◽  
M.A Villanueva-Cuellar ◽  
C Alvarez y Garcı́a ◽  
...  

Author(s):  
M.A. Ramírez-Torres ◽  
J. Rodríguez-Pezino ◽  
M. Zambrana-Castafleda ◽  
J. Lira-Plascencia ◽  
A. Parra

2020 ◽  
Vol 9 (8) ◽  
pp. 2635
Author(s):  
Caro Minschart ◽  
Toon Maes ◽  
Christophe De Block ◽  
Inge Van Pottelbergh ◽  
Nele Myngheer ◽  
...  

The aims of the ‘Mobile-based lifestyle intervention in women with glucose intolerance after gestational diabetes mellitus (GDM)’ study (MELINDA) are: (1) to evaluate the prevalence and risk factors of glucose intolerance after a recent history of GDM; and (2) to evaluate the efficacy and feasibility of a telephone- and mobile-based lifestyle intervention in women with glucose intolerance after GDM. This is a Belgian multicenter randomized controlled trial (RCT) in seven hospitals with the aim of recruiting 236 women. Women in the intervention group will receive a blended program, based on one face-to-face education session and further follow-up through a mobile application and monthly telephone advice. Women in the control group will receive follow-up as in normal routine with referral to primary care. Participants will receive an oral glucose tolerance test (OGTT) one year after baseline. Primary endpoint is the frequency of weight goal achievement (≥5% weight loss if pre-pregnancy BMI ≥ 25 Kg/m2 or return to pre-gravid weight if BMI < 25 Kg/m2). At each visit blood samples are collected, anthropometric measurements are obtained, and self-administered questionnaires are completed. Recruitment began in May 2019.


Sign in / Sign up

Export Citation Format

Share Document